Market Overview

Analysis: Positioning to Benefit within Biglari, Trustmark, Allscripts Healthcare Solutions, Agios Pharmaceuticals, Roadrunner Transportation, and OSI — Research Highlights Growth, Revenue, and Consolidated Results

Share:

NEW YORK, June 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Biglari Holdings Inc. (NYSE:BH), Trustmark Corporation (NASDAQ:TRMK), Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX), Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), Roadrunner Transportation Systems, Inc (NYSE:RRTS), and OSI Systems, Inc. (NASDAQ:OSIS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

BH DOWNLOAD: http://Fundamental-Markets.com/register/?so=BH
TRMK DOWNLOAD: http://Fundamental-Markets.com/register/?so=TRMK
MDRX DOWNLOAD: http://Fundamental-Markets.com/register/?so=MDRX
AGIO DOWNLOAD: http://Fundamental-Markets.com/register/?so=AGIO
RRTS DOWNLOAD: http://Fundamental-Markets.com/register/?so=RRTS
OSIS DOWNLOAD: http://Fundamental-Markets.com/register/?so=OSIS

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Biglari Holdings Inc. (NYSE:BH), Trustmark Corporation (NASDAQ:TRMK), Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX), Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), Roadrunner Transportation Systems, Inc (NYSE:RRTS), and OSI Systems, Inc. (NASDAQ:OSIS) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed April 30th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

BIGLARI HOLDINGS INC. (BH) REPORT OVERVIEW

Biglari's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Biglari reported revenue of $209.22MM vs $205.99MM (up 1.57%) and basic earnings per share $56.53 vs $59.05 (down 4.27%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Biglari reported revenue of $839.80MM vs $850.08MM (down 1.21%) and basic earnings per share $40.80 vs $81.37 (down 49.86%). Biglari is expected to report earnings on August 3rd, 2018. The report will be for the fiscal period ending June 30th, 2018.

To read the full Biglari Holdings Inc. (BH) report, download it here: http://Fundamental-Markets.com/register/?so=BH

-----------------------------------------

TRUSTMARK CORPORATION (TRMK) REPORT OVERVIEW

Trustmark's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Trustmark reported interest income of $115.64MM vs $104.91MM (up 10.23%) and basic earnings per share $0.54 vs $0.46 (up 17.39%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Trustmark reported interest income of $449.80MM vs $412.08MM (up 9.15%) and basic earnings per share $1.56 vs $1.60 (down 2.50%). Trustmark is expected to report earnings on July 24th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.47. The estimated EPS forecast for the next fiscal year is $2.30 and is expected to report on January 22nd, 2019.

To read the full Trustmark Corporation (TRMK) report, download it here: http://Fundamental-Markets.com/register/?so=TRMK

-----------------------------------------

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX) REPORT OVERVIEW

Allscripts Healthcare Solutions' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Allscripts Healthcare Solutions reported revenue of $513.93MM vs $413.48MM (up 24.29%) and basic earnings per share -$0.22 vs -$0.11. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Allscripts Healthcare Solutions reported revenue of $1,806.34MM vs $1,549.90MM (up 16.55%) and basic earnings per share -$1.09 vs -$0.14. Allscripts Healthcare Solutions is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.11. The estimated EPS forecast for the next fiscal year is $0.66 and is expected to report on February 21st, 2019.

To read the full Allscripts Healthcare Solutions, Inc. (MDRX) report, download it here: http://Fundamental-Markets.com/register/?so=MDRX

-----------------------------------------

AGIOS PHARMACEUTICALS, INC. (AGIO) REPORT OVERVIEW

Agios Pharmaceuticals' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Agios Pharmaceuticals reported revenue of $8.76MM vs $10.51MM (down 16.62%) and basic earnings per share -$1.63 vs -$1.56. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Agios Pharmaceuticals reported revenue of $43.01MM vs $69.89MM (down 38.46%) and basic earnings per share -$6.75 vs -$5.07. Agios Pharmaceuticals is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$1.78. The estimated EPS forecast for the next fiscal year is -$6.06 and is expected to report on February 13th, 2019.

To read the full Agios Pharmaceuticals, Inc. (AGIO) report, download it here: http://Fundamental-Markets.com/register/?so=AGIO

-----------------------------------------

ROADRUNNER TRANSPORTATION SYSTEMS, INC (RRTS) REPORT OVERVIEW

Roadrunner Transportation's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Roadrunner Transportation reported revenue of $560.36MM vs $551.23MM (up 1.66%) and basic earnings per share -$0.60 vs -$1.01. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Roadrunner Transportation reported revenue of $2,091.29MM vs $2,033.20MM (up 2.86%) and basic earnings per share -$2.37 vs -$9.40. Roadrunner Transportation is expected to report earnings on September 19th, 2018. The report will be for the fiscal period ending March 31st, 2018.

To read the full Roadrunner Transportation Systems, Inc (RRTS) report, download it here: http://Fundamental-Markets.com/register/?so=RRTS

-----------------------------------------

OSI SYSTEMS, INC. (OSIS) REPORT OVERVIEW

OSI's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, OSI reported revenue of $267.30MM vs $245.15MM (up 9.04%) and basic earnings per share $0.14 vs $0.74 (down 81.08%). For the twelve months ended June 30th, 2017 vs June 30th, 2016, OSI reported revenue of $960.95MM vs $829.66MM (up 15.82%) and basic earnings per share $1.12 vs $1.35 (down 17.04%). OSI is expected to report earnings on August 23rd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.02. The estimated EPS forecast for the next fiscal year is $3.79 and is expected to report on August 23rd, 2018.

To read the full OSI Systems, Inc. (OSIS) report, download it here: http://Fundamental-Markets.com/register/?so=OSIS

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Primary Logo

View Comments and Join the Discussion!